 | |
| PHIN2013-2 | Quality assurance and pharmaceutical management
- Economic aspects of drug development
- Principles of pharmaceutical management
- Quality assurance, part a: basic concepts and the organisation of quality assurance
- Quality assurance, part b: Process analytical technology and risk analysis
- English used in the pharmaceutical industry
- Pharmaceutical marketing
 |
|
| Duration : | Economic aspects of drug development : 10h Th
Principles of pharmaceutical management : 10h Th
Quality assurance, part a: basic concepts and the organisation of quality assurance : 20h Th
Quality assurance, part b: Process analytical technology and risk analysis : 7,5h Th
English used in the pharmaceutical industry : 20h Th
Pharmaceutical marketing : 5h Th
|
|
| Credits/ECTS : |
|
|
| Holder(s) : | Economic aspects of drug development : Jean‑Pierre Delporte
Principles of pharmaceutical management : J.‑M. Vanderhofstadt
Quality assurance, part a: basic concepts and the organisation of quality assurance : J. Scouvart
Quality assurance, part b: Process analytical technology and risk analysis : X. Marcelis
English used in the pharmaceutical industry : E. Dagneaux, D. Lambert
Pharmaceutical marketing : Vincent Bierlaire
|
|
| Coordinator : | Philippe Hubert |
|
| Language : | Langue française |
|
| Course contents : |
 | | Economic aspects of drug development |
|
| General structure of the Belgian health system - Definition of health economy, objectives and specificities - Analysis of the consumption of health resources, including drugs, and its determinants - Different ways to regulate the supply and demand of health resources - Cost of drug misuse and side effects - Methodology of drug utilisation studies, a practical example - Methodology of pharmacoeconomy studies, practical example |
|
|
| Course objective : |
| | Economic aspects of drug development |
|
| - Provide students with a rough description of the Belgian health system structure
- Starting from the specificities of the consumption of health resources, including medicines, to specify the objectives of health economy and pharmacoeconomy
- Critically analyse the mechanisms and parameters influencing the growth of drug expenditures and the different means developed in most countries to contain it.
- Teach the methodology of drug utilisation analysis and of pharmacoeconomy studies |
|
|
| Prerequisites : |
| | Economic aspects of drug development |
|
| The teaching is prodided in the frame of the Complementary Master in Industrial Pharmacy to students holding a diploma of pharmacist or a Master in Pharmaceutical Sciences obtained in a EU university or a diploma considered as equivalent, delivered by a non EU university |
|
|
| Workshops : |
| | Economic aspects of drug development |
|
| None |
|
|
| Organization : |
| | Economic aspects of drug development |
|
| 3 half-days , 1st semester. |
|
|
| Written notes : |
| | Economic aspects of drug development |
|
| Detailed written notes and slides' copy |
|
|
| Assessment : |
| | Economic aspects of drug development |
|
| Oral test in June |
|
|
| Contacts : |
| | Economic aspects of drug development |
|
| Professor Jean-Pierre Delporte
Hospital Pharmacy and Pharmacoeconomy
Department of Pharmacy
Avenue de l'Hôpital, 3, B36
4000 Liège
Phone: 32 4 366 43 01
Fax: 32 4 366 43 02
Email: jpdelporte@ulg.ac.be |
|
|
| Remarks : |
| | Economic aspects of drug development |
|
| None |
|
|
